Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 175   

Articles published

SNY 42.31 +0.41 (0.98%)
price chart
Attention Seekers of Healthcare: AstraZeneca plc (ADR) (NYSE:AZN), Sanofi SA ...
AstraZeneca plc (ADR) (NYSE:AZN) shares went down -0.33% or -0.10 points to reach at $30.24 during the course of session. The stock traded in the range of $30.12 - $30.46 during its most recent trading session.
Sanofi SA (ADR) and Diabetes: Things Are Not Working Out
Sanofi SA (NYSE:SNY) came into the spotlight after Food and Drug Administration (FDA) initiated a debate in association with its Diabetes Mellitus Type II combo drug LixiLan pointing out number of questions regarding the safety and clinical efficacy ...
Sanofi's LixiLan Faces Scrutiny From FDA  Bidness ETC
Sanofi SA (ADR) (SNY) Confirmed Confidentiality Agreement with Medivation Inc ...
As Medivation Inc (NASDAQ:MDVN) is headed towards a selloff, it is in talks with many parties who seek to buy the company. With Board of Directors consent, Medivation and Sanofi SA (ADR) (NYSE:SNY) have entered into confidentiality agreement.
Medivation Bidders Will Have To Price In Talazoparib; BMO Sees $68-$76 ...  Benzinga
Sanofi SA (ADR) - DICE Deal To Replace Injectables With Oral Formulations
Sanofi SA (ADR) (NYSE:SNY) has announced it has signed an agreement with DiCE Molecules, for the research and development of novel molecules that can replace injectables with oral formulations, for certain diseases.
Sanofi and DICE on a Research Venture to Replace Injections with New Drugs  Bidness ETC
Sanofi SA (ADR) Scouts For New Cancer Treatments That Harness Immune Cells
Pharmaceutical giant Sanofi is partnering with two biotech companies -- Evotec AG in Hamburg, Germany, and Apeiron Biologics AG in Vienna, Austria - in its latest effort to develop a drug that harnesses the body's own immune system in the fight against ...
Sanofi SA (ADR) (NYSE:SNY) Looking To Acquire Medivation Inc (NASDAQ:MDVN) For ...
Sanofi SA (ADR) (NYSE:SNY) has made public its intention of acquiring Medivation Inc (NASDAQ:MDVN), having tabled a $9.3 billion takeover bid.
Sanofi Turns Hostile, Makes $9.3 Billion Bid for Medivation: A Smart Move?  Bidness ETC
Why Medivation Will Likely Reject Sanofi's $52.50/Share Buyout Offer  Benzinga
Pfizer Inc, Sanofi SA (ADR), Novartis AG (ADR): Who Will Acquire Medivation Inc?
The drugmakers are looking for M&A to expand their drug portfolios in order to make their drug pipeline more robust and competitive.
Medivation Inc Acquisition: Sanofi SA (ADR) Won't Take No for an Answer  Bidness ETC
If Medivation Is Sold, Brean Thinks It'll Be For Far More Than Sanofi ...  Benzinga
HC Stocks Zone: Medtronic PLC (NYSE:MDT), Sanofi SA (ADR) (NYSE:SNY)
Shares of Medtronic PLC (NYSE:MDT) ended Tuesday session in green amid volatile trading. The shares closed up +0.19 points or 0.22% at $88.38 with 2.99 million shares getting traded.
HC Stocks Highlights: Amgen, Inc. (NASDAQ:AMGN), Sanofi SA (ADR) (NYSE:SNY)
Shares of Sanofi SA (ADR) (NYSE:SNY) ended Wednesday session in green amid volatile trading. The shares closed up +0.70 points or 1.70% at $41.89 with 817,804.00 shares getting traded.
Sanofi SA (ADR) on Focus After Raising In Today's Session
The stock of Sanofi SA (ADR) (NYSE:SNY) is a huge mover today! About 628,023 shares traded hands. Sanofi SA (ADR) (NYSE:SNY) has declined 2.42% since December 15, 2015 and is downtrending. It has underperformed by 8.38% the S&P500.